Australia markets closed

FLGT Jan 2023 30.000 put

OPR - OPR Delayed price. Currency in USD
Add to watchlist
0.90000.0000 (0.00%)
As of 11:36AM EDT. Market open.
Full screen
Previous close0.9000
Open0.6100
Bid0.3500
Ask0.9000
Strike30.00
Expiry date2023-01-20
Day's range0.6100 - 0.9000
Contract rangeN/A
Volume12
Open interest63
  • Motley Fool

    Fulgent Genetics, Inc. (FLGT) Q2 2022 Earnings Call Transcript

    On the call today are Ming Hsieh, chief executive officer; Paul Kim, chief financial officer; Dr. Larry Weiss, chief medical officer; Brandon Perthuis, chief commercial officer. The company's press release discussing its financial results is available in the investor relations section of the company's website, fulgentgenetics.com.

  • Motley Fool

    Why I Bought More of This Under-the-Radar Stock

    In this segment of "Backstage Pass" on Motley Fool Live, recorded on July 27, Fool.com contributors Matt Frankel and Jason Hall discuss some of the reasons why it could be a good time to invest in the business. Matt Frankel: So Jason, why don't you give us a quick overview of Fulgent and why you doubled down on it or however much you added? This is a company that's very much grouped in with the COVID stocks, so Ming Hsieh, the founder of the company, has a long history of success as an entrepreneur.

  • Zacks

    Fulgent Genetics, Inc. (FLGT) Q2 Earnings and Revenues Beat Estimates

    Fulgent Genetics, Inc. (FLGT) delivered earnings and revenue surprises of 6.85% and 2.15%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?